Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The test measures a protein called procalcitonin. Patients with high levels of the protein face a greater risk of severe sepsis or septic shock. Since the window of treatment for sepsis is narrow, the test allows physicians and other healthcare professionals to detect this risk before it is too late, according to the report.
Approximately 300 U.S. hospitals are currently using the test.
Related Articles on Sepsis:
NIH Funding UPMC’s 5-Year Study on Sepsis
Jury: Two Pennsylvania Physicians Acted Negligently in Patient’s Sepsis-Related Death
13 Indications for Handwashing and Hand Antisepsis
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.